Currie Mark G — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Currie Mark G has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Currie Mark G is the name as listed in the most recent SEC filing dated 2026-06-17 for Ironwood Pharmaceuticals Inc. The available public context does not provide a clear job title, biographical details, or a confirmed role (employee, officer, or director). Ironwood Pharmaceuticals is a biotechnology company focused on GI therapies. Given the lack of additional public information tied to this exact name, Currie Mark G’s precise background, education, tenure, and achievements remain undetermined based on the provided SEC context.
Currie Mark G is the name as listed in the most recent SEC filing dated 2026-06-17 for Ironwood Pharmaceuticals Inc. The available public context does not provide a clear job title, biographical details, or a confirmed role (employee, officer, or director). Ironwood Pharmaceuticals is a biotechnology company focused on GI therapies. Given the lack of additional public informati…
How many SEC Form 4 filings has Currie Mark G submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Currie Mark G's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
